CD4 T细胞在抗肿瘤免疫中的相反作用。
The opposing roles of CD4 T cells in anti-tumour immunity.
作者信息
Ahrends Tomasz, Borst Jannie
机构信息
Division of Tumour Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
出版信息
Immunology. 2018 Apr 27;154(4):582-92. doi: 10.1111/imm.12941.
Abstract
Cancer immunotherapy focuses mainly on anti-tumour activity of CD8 cytotoxic T lymphocytes (CTLs). CTLs can directly kill all tumour cell types, provided they carry recognizable antigens. However, CD4 T cells also play important roles in anti-tumour immunity. CD4 T cells can either suppress or promote the anti-tumour CTL response, either in secondary lymphoid organs or in the tumour. In this review, we highlight opposing mechanisms of conventional and regulatory T cells at both sites. We outline how current cancer immunotherapy strategies affect both subsets and how selective modulation of each subset is important to maximize the clinical response of cancer patients.
摘要
癌症免疫疗法主要聚焦于CD8细胞毒性T淋巴细胞（CTL）的抗肿瘤活性。只要肿瘤细胞携带可识别的抗原，CTL就能直接杀死所有类型的肿瘤细胞。然而，CD4 T细胞在抗肿瘤免疫中也发挥着重要作用。CD4 T细胞在次级淋巴器官或肿瘤中既可以抑制也可以促进抗肿瘤CTL反应。在本综述中，我们着重介绍了传统T细胞和调节性T细胞在这两个部位的相反作用机制。我们概述了当前的癌症免疫疗法策略如何影响这两个亚群，以及对每个亚群进行选择性调节对于最大化癌症患者的临床反应为何至关重要。
相似文献
1
The opposing roles of CD4 T cells in anti-tumour immunity.CD4 T细胞在抗肿瘤免疫中的相反作用。
Immunology. 2018 Apr 27;154(4):582-92. doi: 10.1111/imm.12941.
2
CD4 T cell help in cancer immunology and immunotherapy.CD4 T 细胞在癌症免疫和免疫治疗中的作用。
Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0.
3
Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.在较高的 CD8(+) T 细胞前体频率下，CD4(+) T 细胞信号对效应细胞毒性 T 淋巴细胞 (CTL) 启动和功能性记忆 CTL 发育的差异需求。
Immunology. 2013 Apr;138(4):298-306. doi: 10.1111/imm.12033.
4
CD4 Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy.CD4 细胞毒性 T 淋巴细胞在癌症免疫和免疫治疗中的作用
Adv Biol (Weinh). 2023 Apr;7(4):e2200169. doi: 10.1002/adbi.202200169. Epub 2022 Oct 4.
5
CD4 Cytotoxic T cells - Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways.CD4 细胞毒性 T 细胞 - 表型、功能和转录网络控制其分化途径。
Immunol Lett. 2022 Jul;247:27-42. doi: 10.1016/j.imlet.2022.05.001. Epub 2022 May 11.
6
Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.抗病毒细胞毒性CD4 T细胞分化的机制。
J Virol. 2021 Sep 9;95(19):e0056621. doi: 10.1128/JVI.00566-21. Epub 2021 Jul 14.
7
Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.肿瘤特异性CTL反应需要四种不同细胞类型的相互作用以及对MHC I类和II类限制性肿瘤抗原的识别。
Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26. doi: 10.1038/icb.1993.36.
8
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞：综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
9
Suppression of murine tumour growth through CD8 cytotoxic T lymphocytes via activated DEC-205 dendritic cells by sequential administration of α-galactosylceramide in vivo.通过在体内序贯给予α-半乳糖神经酰胺，经活化的DEC-205树突状细胞介导CD8细胞毒性T淋巴细胞抑制小鼠肿瘤生长。
Immunology. 2017 Jul;151(3):324-339. doi: 10.1111/imm.12733. Epub 2017 Apr 18.
10
CD4 CTL, a Cytotoxic Subset of CD4 T Cells, Their Differentiation and Function.CD4细胞毒性T淋巴细胞，CD4 T细胞的一种细胞毒性亚群，其分化与功能。
Front Immunol. 2017 Feb 23;8:194. doi: 10.3389/fimmu.2017.00194. eCollection 2017.
引用本文的文献
1
B7-H3 in Cancer Immunotherapy-Prospects and Challenges: A Review of the Literature.癌症免疫治疗中的B7-H3：前景与挑战——文献综述
Cells. 2025 Aug 6;14(15):1209. doi: 10.3390/cells14151209.
2
Personalized risk stratification in colorectal cancer via PIANOS system.通过PIANOS系统对结直肠癌进行个性化风险分层。
Nat Commun. 2025 Jul 16;16(1):6561. doi: 10.1038/s41467-025-61713-1.
3
Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade.胃癌中的半乳糖凝集素-9和Tim-3：一个驱动T细胞耗竭和调节性T细胞介导的免疫抑制的检查点轴，独立于抗程序性死亡蛋白1阻断作用
Front Immunol. 2025 Jul 1;16:1600792. doi: 10.3389/fimmu.2025.1600792. eCollection 2025.
4
Harnessing agent-based frameworks in CellAgentChat to unravel cell-cell interactions from single-cell and spatial transcriptomics.利用CellAgentChat中基于代理的框架从单细胞和空间转录组学中解析细胞间相互作用。
Genome Res. 2025 Jun 2. doi: 10.1101/gr.279771.124.
5
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies.实体瘤中的免疫调节与免疫治疗：耐药机制及潜在治疗策略
Int J Mol Sci. 2025 Mar 24;26(7):2923. doi: 10.3390/ijms26072923.
6
B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the Literature.B7H3在胃肠道肿瘤中的作用：在免疫调节和癌症进展中的作用——文献综述
Cells. 2025 Apr 2;14(7):530. doi: 10.3390/cells14070530.
7
Identification of a Prognostic Signature Based on Tumor-Infiltrating B Lymphocyte mRNA in Head and Neck Squamous Cell Carcinoma.基于头颈部鳞状细胞癌中肿瘤浸润B淋巴细胞mRNA的预后特征识别
J Immunol Res. 2025 Mar 19;2025:9375885. doi: 10.1155/jimr/9375885. eCollection 2025.
8
Prognostic value of prognostic nutritional index in patients with nasopharyngeal carcinoma treated with endostar and concurrent chemoradiotherapy.恩度联合同步放化疗治疗鼻咽癌患者中预后营养指数的预后价值
Support Care Cancer. 2025 Feb 26;33(3):226. doi: 10.1007/s00520-025-09280-5.
9
Adoptive T Cell Therapy Targeting MAGE-A4.靶向黑素瘤相关抗原A4的过继性T细胞疗法
Cancers (Basel). 2025 Jan 26;17(3):413. doi: 10.3390/cancers17030413.
10
Lymphocyte infiltration in breast cancer: A promising prognostic indicator.乳腺癌中的淋巴细胞浸润：一个有前景的预后指标。
Medicine (Baltimore). 2024 Dec 6;103(49):e40845. doi: 10.1097/MD.0000000000040845.
本文引用的文献
1
CD4 T Helper Cells Play a Key Role in Maintaining Diabetogenic CD8 T Cell Function in the Pancreas.CD4辅助性T细胞在维持胰腺中致糖尿病的CD8 T细胞功能方面发挥关键作用。
Front Immunol. 2018 Jan 18;8:2001. doi: 10.3389/fimmu.2017.02001. eCollection 2017.
2
Regulatory T cells constrain the TCR repertoire of antigen-stimulated conventional CD4 T cells.调节性 T 细胞限制抗原刺激的常规 CD4 T 细胞的 TCR 库。
EMBO J. 2018 Feb 1;37(3):398-412. doi: 10.15252/embj.201796881. Epub 2017 Dec 20.
3
Conventional CD4 T cells present bacterial antigens to induce cytotoxic and memory CD8 T cell responses.常规 CD4 T 细胞呈递细菌抗原以诱导细胞毒性和记忆 CD8 T 细胞反应。
Nat Commun. 2017 Nov 17;8(1):1591. doi: 10.1038/s41467-017-01661-7.
4
CD4 T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.CD4 T 细胞辅助赋予细胞毒性 T 细胞效应器程序，包括共抑制受体下调和增加组织侵袭性。
Immunity. 2017 Nov 21;47(5):848-861.e5. doi: 10.1016/j.immuni.2017.10.009. Epub 2017 Nov 7.
5
CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.CD27介导的调节性T细胞耗竭和效应性T细胞共刺激均有助于抗肿瘤疗效。
J Immunol. 2017 Dec 15;199(12):4110-4123. doi: 10.4049/jimmunol.1700606. Epub 2017 Nov 6.
6
The Dual Role of Treg in Cancer.调节性T细胞在癌症中的双重作用
Scand J Immunol. 2017 Dec;86(6):436-443. doi: 10.1111/sji.12615.
7
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial.改良安卡拉痘苗病毒-5T4 联合低剂量环磷酰胺对转移性结直肠癌患者抗肿瘤免疫的影响：一项随机临床试验。
JAMA Oncol. 2017 Oct 12;3(10):e172579. doi: 10.1001/jamaoncol.2017.2579.
8
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.不同的细胞机制是抗CTLA-4和抗PD-1检查点阻断的基础。
Cell. 2017 Sep 7;170(6):1120-1133.e17. doi: 10.1016/j.cell.2017.07.024. Epub 2017 Aug 10.
9
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.癌症中调节性T细胞的代谢调控：免疫治疗的机遇
Trends Cancer. 2017 Aug;3(8):583-592. doi: 10.1016/j.trecan.2017.06.005. Epub 2017 Jul 14.
10
Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.调节性T细胞与肿瘤相关树突状细胞之间的串扰削弱了胰腺癌的抗肿瘤免疫。
Cell Rep. 2017 Jul 18;20(3):558-571. doi: 10.1016/j.celrep.2017.06.062.
Zotero 插件